Deadline for applications: Friday 21 July
MRC ITTP PhD studentships are administered and funded through the MRC Toxicology Unit with the aim of training the next generation of toxicologists.
Applications should be submitted from potential academic supervisors with partners in industry, government agencies or other universities. Projects should combine cutting-edge science from any discipline with toxicology to address current hot topics in the field.
Applicants are first required to attend a virtual interactive meeting hosted by the MRC Toxicology Unit on Tuesday 23rd May 2023 from 10 am to 12.30 pm. To register for this meeting, please email Kirsti Hornigold (ittp@mrc-tox.cam.ac.uk) with your name, email and affiliation no later than Friday, 5th May 2023. This meeting is an excellent way to meet new collaborators.
Deadline for applications: Sunday 28 May 2023 (extended).
Wellcome has awarded an Institutional Translation Partnership Award (iTPA) to the University of Cambridge. Funding of up to £20,000 is available for projects in the remit of the Future of Therapeutics which progress translational interdisciplinary work in the priority areas of Wellcome: Infectious Diseases, Climate and Health and Mental Health in addition to Smart Diagnostics and Healthy Ageing.
Funding can be used for projects including:
Funding cannot be used to support lab work, studentships and salaries.
The Lead Applicant may be a University of Cambridge postdoctoral researcher (holding a contract for the duration of the funding) with a Principal Investigator at the University of Cambridge as a co-applicant. We strongly encourage cross-disciplinary applications. We anticipate that all projects should be completed within 6 months of the award of funding.
For more information please contact Caroline Reynolds to arrange to discuss your application.
Deadline for applications: Sunday 28 May 2023 (extended)
Funding of up to £15,000 is available from the Wellcome Institutional Translation Partnership Award (iTPA) for University of Cambridge departments/institutes to support activities related to the translation of basic research into therapeutics, medtech or diagnostics at a departmental level.
Applications should be led by Translational Champions and/or Heads of Departments/Institutes on behalf of their respective departments.
Funding cannot be used for direct support of any specific project within the department, for the procurement of any equipment or consumables, or for any wet lab work.
Examples of how funding could be used:
For more details and an initial discussion about your proposal please contact Caroline Reynolds.
Deadline for applications: 29th May 2023.
The 2023 Sanofi iAwards Europe scheme funds collaborative pilot projects between University researchers and Sanofi scientists in Sanofi’s strategic priority areas, with the opportunity for successful projects to be taken forward for further funding and collaboration. Each pilot project would last for 12 months at a maximum cost of 120k€ (at 120% FEC, as per usual University pricing guidelines) and would be given a dedicated Sanofi project champion and in-kind resources and expertise as required.
Expressions of interest are invited for potential iAwards projects in the following therapeutic areas:
Proposals could address:
Expressions of interest must be submitted using the Sanofi pre-proposal template and must provide objectives, including a strong rationale for benefit to patients (500 words) and a work-plan achievable in 12 months (500 words), along with a short biography of the lead applicant. Further descriptions of the therapeutic areas of interest, information about the call and the pre-proposal template can be found on CATS website.
Please contact Dr Meghana Patel at meghana.patel@admin.cam.ac.uk for further queries.
Deadline for applications: Monday 03rd July 2023
This is to announce that the AstraZeneca-funded Non-Clinical PhD studentship program will be inviting applications from University of Cambridge principle investigators from 9th May 2023. Further details about the call and how to apply can be found CATS website.
Remit: The aim of this programme is to fund 4 year Non-Clinical PhD studentships at the University of Cambridge (UoC) for talented graduates in research areas which align with the strategic interests of AstraZeneca (AZ). The three broad areas of research interests are
Research topics aligning to these three broad areas can be found guidance document which can be downloaded from CATS website.
Eligibility and Criteria: All applications should be submitted as a partnership between identified principle investigators employed by the UoC and AZ. Further details on the criteria for submissions can be found in the guidance document on CATS website.
Funding: Each funded studentship covers
Posted on 27/04/2023
